Financial Snapshot

Revenue
$2.764M
TTM
Gross Margin
13.47%
TTM
Net Earnings
-$7.670M
TTM
Current Assets
Q1 2024
Current Liabilities
Q1 2024
Current Ratio
22.77%
Q1 2024
Total Assets
Q1 2024
Total Liabilities
Q1 2024
Book Value
-$9.623M
Q1 2024
Cash
Q1 2024
P/E
-0.1851
Nov 14, 2024 EST
Free Cash Flow
-$1.623M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $2.385M $1.627M $2.060M $2.071M $345.7K $0.00 $0.00 $0.00
YoY Change 46.59% -21.01% -0.55% 499.11%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Revenue $2.385M $1.627M $2.060M $2.071M $345.7K $0.00 $0.00 $0.00
Cost Of Revenue $1.263M $1.231M $6.478M $2.720M $2.046M
Gross Profit $1.122M $396.5K -$4.418M -$648.6K -$1.700M
Gross Profit Margin 47.04% 24.37% -214.53% -31.32% -491.91%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Selling, General & Admin $1.456M $1.093M $1.519M $5.329M $8.950M $2.136M $1.719M $1.228M
YoY Change 33.2% -28.01% -71.5% -40.46% 318.97% 24.28% 39.96%
% of Gross Profit 129.81% 275.77%
Research & Development $0.00 $22.10K $300.0K $356.1K $369.3K
YoY Change -100.0% -92.63% -15.75% -3.59%
% of Gross Profit
Depreciation & Amortization $1.713M $1.670M $1.737M $819.8K $892.3K $0.00
YoY Change 2.59% -3.89% 111.9% -8.12%
% of Gross Profit 152.67% 421.14%
Operating Expenses $6.668M $6.049M $1.519M $5.329M $8.972M $2.436M $2.075M $1.597M
YoY Change 10.24% 298.29% -71.5% -40.61% 268.29% 17.41% 29.89%
Operating Profit -$5.546M -$5.652M -$5.937M -$5.978M -$10.67M
YoY Change -1.88% -4.8% -0.68% -43.99%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Interest Expense $1.556M $2.048M $63.10K -$489.8K -$2.351M -$1.293M -$735.8K
YoY Change -24.04% 3145.91% -112.88% -79.16% 81.78% 75.76%
% of Operating Profit
Other Income/Expense, Net -$2.469M -$3.490M $633.2K -$23.00K $0.00 $0.00 -$1.450K
YoY Change -29.26% -651.19% -2853.22% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Pretax Income -$8.015M -$9.143M -$4.782M -$10.94M -$10.02M -$4.337M -$3.861M -$1.603M
YoY Change -12.33% 91.17% -56.29% 9.21% 130.99% 12.35% 140.85%
Income Tax $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$8.015M -$9.143M -$4.782M -$9.461M -$9.481M -$4.337M -$3.861M -$1.603M
YoY Change -12.33% 91.17% -49.45% -0.22% 118.6% 12.35% 140.85%
Net Earnings / Revenue -336.08% -561.94% -232.2% -456.82% -2742.81%
Basic Earnings Per Share -$0.48 -$0.62 -$0.28
Diluted Earnings Per Share -$0.48 -$0.62 -$268.4K -$5.332M -$7.832M -$25.50M -$25.48M -$18.68M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Cash & Short-Term Investments $115.9K $1.114M $3.811M $25.14K $18.41K $1.960K $161.2K $1.055M
YoY Change -89.6% -70.76% 15060.14% 36.56% 839.29% -98.78% -84.72%
Cash & Equivalents $100.9K $6.950K $19.77K $25.14K $18.41K $1.960K $161.2K $1.055M
Short-Term Investments $14.93K $1.107M $3.791M
Other Short-Term Assets $263.0K $113.1K $278.3K $15.26K $870.9K $12.33K $11.46K $1.020M
YoY Change 132.54% -59.36% 1723.92% -98.25% 6963.58% 7.59% -98.88%
Inventory $4.014M $4.449M $4.264M $10.71K $1.338M
Prepaid Expenses
Receivables $264.0K $206.1K $244.5K $0.00 $74.59K
Other Receivables $0.00 $500.0K $500.0K $0.00 $127.5K
Total Short-Term Assets $4.656M $6.382M $9.098M $51.11K $2.429M $14.29K $172.7K $2.075M
YoY Change -27.04% -29.85% 17701.53% -97.9% 16899.58% -91.72% -91.68%
Property, Plant & Equipment $10.31M $10.92M $12.44M $20.16K $2.651M $0.00
YoY Change -5.55% -12.2% 61581.94% -99.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $2.572M $0.00
YoY Change -100.0%
Total Long-Term Assets $13.33M $13.11M $14.69M $20.16K $7.370M $0.00 $0.00 $50.00K
YoY Change 1.68% -10.75% 72743.7% -99.73% -100.0%
Total Assets $17.98M $19.49M $23.78M $71.27K $9.799M $14.29K $172.7K $2.125M
YoY Change
Accounts Payable $4.630M $2.666M $1.686M $2.534M $1.897M $923.4K $735.1K $566.5K
YoY Change 73.65% 58.15% -33.47% 33.59% 105.42% 25.63% 29.75%
Accrued Expenses $2.914M $2.090M $1.624M $941.6K $806.8K $113.2K $597.5K $58.48K
YoY Change 39.4% 28.7% 72.49% 16.71% 612.8% -81.06% 921.67%
Deferred Revenue
YoY Change
Short-Term Debt $11.90M $10.32M $6.761M $115.5K $55.56K $51.40K $48.00K $0.00
YoY Change 15.38% 52.6% 5752.64% 107.92% 8.09% 7.08%
Long-Term Debt Due $826.6K $85.91K $491.8K $57.80K
YoY Change 862.2% -82.53% 750.85%
Total Short-Term Liabilities $19.45M $15.07M $10.07M $4.905M $4.191M $3.339M $2.388M $625.0K
YoY Change 29.02% 49.68% 105.33% 17.05% 25.51% 39.8% 282.15%
Long-Term Debt $0.00 $0.00 $0.00 $205.2K $100.0K $100.0K $0.00 $0.00
YoY Change -100.0% 105.17% 0.0%
Other Long-Term Liabilities $6.827M $6.560M $6.610M $0.00 $1.827M
YoY Change 4.07% -0.76% -100.0%
Total Long-Term Liabilities $6.827M $6.560M $6.610M $205.2K $1.927M $100.0K $0.00 $0.00
YoY Change 4.07% -0.76% 3121.89% -89.35% 1826.89%
Total Liabilities $26.27M $21.63M $16.68M $3.092M $5.580M $3.439M $2.388M $625.0K
YoY Change 21.45% 29.69% 439.54% -44.59% 62.27% 43.98% 282.15%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016
Basic Shares Outstanding 16.63M shares 14.86M shares 16.92M shares
Diluted Shares Outstanding 16.63M shares 14.86M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.4198 Million

About Panacea Life Sciences Holdings Inc

Panacea Life Sciences Holdings, Inc. engages in the development and production of medically relevant, legal, hemp-derived cannabinoid products for consumers and pets. The company is headquartered in Greenwood Village, Colorado and currently employs 40 full-time employees. The company went IPO on 2015-11-24. The company specializes in the development, manufacturing, research, and distribution of products with natural health and wellness market segment for both humans and animals. The Company’s subsidiary, Panacea Life Sciences, Inc. (PLS) is engaged in the production, distribution, research, and manufacturing of nutraceuticals, cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products. The firm also offers natural remedies within its branded product lines for every aspect of life, including PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life. The company also operates 51,000 square foot current good manufacturing practice (cGMP) facility located in Golden, Colorado. The Company, through Panacea Life Sciences Holdings, Inc., manages six retail locations and a distribution center situated in the Tampa, Florida area.

Industry: Medicinal Chemicals & Botanical Products Peers: Kaya Holdings Inc CANNABIS STRATEGIC VENTURES RespireRx Pharmaceuticals Inc Earth Science Tech Inc Johnson & Johnson